Published in Cancer Weekly, June 8th, 2004
Dr. Charles M. Perou, assistant professor of genetics and pathology and laboratory medicine at the University of North Carolina at Chapel Hill School of Medicine, led the study, which was published in the May 18 issue of Cancer Cell.
Researchers based their findings on the gene expression patterns of 60 head and neck tumor samples from patients at the University's hospital. The samples were assayed using DNA microarrays.
The study identified four tumor gene expression patterns that may serve as biomarkers of prognosis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-06-08)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.